Navigation Links
Misys Facilitates Masraf Al Rayan's Expansion of Islamic Banking Operations
Date:5/6/2008

LONDON, May 6 /PRNewswire-FirstCall/ -- Misys plc (FTSE: MSY.L), the global application software and services company, today announces that its core banking and trade services solutions have been selected by Masraf Al Rayan to build a true Islamic solution for its consumer and commercial customers.

Misys was chosen as the best partner for Masraf Al Rayan over other solutions from five vendors because of its proven expertise in Islamic finance and credibility in the region.

"Misys and its core banking solution, Equation, has an excellent track record in our market for delivering solutions that fully support Islamic banking and finance," comments Said Mohamed, Chief Operating Office at Masraf Al Rayan. We have plans to build our business quickly and expand our branch network rapidly in Qatar and in throughout the region; we therefore needed a reliable and proven solution that minimized the risk in the project and was able to scale at the rate at which we are planning to grow."

Masraf Al Rayan, which recently won the "Best New Islamic Bank" award, is focused on providing commercial and investment banking solutions with an entirely Sharia'a compliant portfolio of products. It also provides its customers a range of consumer services such as vehicle, home finance and goods finance.

The bank is already building a reputation for innovative products and a high standard of customer service. "We are dedicated to delivering superior customer satisfaction consistently," continues Said Mohamed. "Misys will enable us to maintain this excellence."

The trade finance sector in Qatar is growing very strongly, mirroring the vibrant economy in the country, underpinned by the success of the petrochemical industry. Exports have surged in recent years, as oil prices have increased and energy export volumes have grown, coupled with a steady influx of imports.

As part of the solution from Misys, the bank needed an integrated system to cope wit
'/>"/>

SOURCE Misys plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. United Commercial Bank Extends its Use of Misys Equation and Trade Innovation Systems to Support its Expansion in Taiwan
2. Mybank Goes Live With Misys Equation to Support Rapid Growth and Meet Future Regulatory Requirements
3. Commerzbank Goes Live With Misys Risk Vision 5.4, Following a Successful, On Schedule Implementation Project
4. Brotman Medical Center Facilitates Restructuring Through Chapter 11 Filing
5. Optimal band imaging with endoscopy facilitates the diagnosis of depressed-type early gastric cancer
6. Interview by Internet Can Decrease Greatest End-of-Life Fears: It Facilitates Creating Effective Advance Directives, Living Wills
7. Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market
8. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia
9. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
10. LehmanMillet Continues Expansion with Strategic Hires
11. U.S. Reps. Oberstar and Walz Discuss DM&E Railroad Expansion With Rochester, Minn. Leaders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...t study follow-up period was too short to draw def...NESDAY, Nov. 25 (HealthDay News) -- In diabetic pa...rs to be no difference in outcomes at one year whe...y with stenting, British researchers report. , ... diabetic patients with coronary artery disease. H...
(Date:11/25/2009)... Evaluation and treatment c... Woodstock (Vocus) November 25, 2009 -- C...nasal vaccines and H1N1 vaccine shots at four Cent...another shipment of vaccine has arrived. The clini... Lake and McHenry and will be open as follows: , ...
(Date:11/25/2009)...rvivors often plagued by neurological symptoms, st...hDay News) -- Neurological side effects are among ...s of testicular cancer who were treated with cispl..., The study included 1,409 Norwegian men treated ...1994 who took part in a follow-up survey conducted...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/-- MISSIONSkincare...$1millionforSt.Jude.AspartofGNC,sannualSt.Jude Tha...y MISSIONSkincare,s new SUPER-C(TM)LipBalm willb...opportunitytomakea$1,$5or$10donationatcheckoutaton...oraisemorethan$1millionforSt.Judeduringtheir2009 T...
(Date:11/25/2009)...,, LittleImprovementShownforthe4thStraightYea...-- Today,LungCancerAlliance-Georgia(LCA-GA)issued...nassessmentofprogressbeingmadeagainstthislethaldis...erAlliance(LCA),theonlynationalorganizationdedicat...ivingwithoratriskforlungcancer. ,, (Logo: http:...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
... OCTOBER 16 WORLD-RENOWNED SCIENTISTS WILL CONVENE...EASE, MEMORY AND AGING, MORGANTOWN, W.Va., Aug. 2...hette Rockefeller Neurosciences Institute,(BRNI) l...nal scientists who are advancing research on Alzhe...
... The Drug Information Asso...cal Imaging Contrast Agent Association (MICAA), th...s (CORAR), PhRMA, and the American Medical Informa...maceutical Products (October 2-3; Bethesda, MD) , ...
...NCOUVER, Aug. 26 /PRNewswire-FirstCall/ - QLT Inc.... USA, Inc., its wholly-owned subsidiary,has entere... Benckiser,Pharmaceuticals Inc. for its Atrigel(R)...se agreement and related asset,purchase agreement,...
...ENZHEN, China Aug. 25 /Xinhua-PRNewswire-FirstCall... MR ), a leading developer, manufacturer,and marke...lect historical,financial figures converted from C...fective April 1, 2008.,Accordingly, Mindray has is...
...nadian study suggests cautions fail to alert docs ... , MONDAY, Aug. 25 (HealthDay News) -- Safety war...iors with dementia. But the overall use of the dru...te 2002 and June 2005, Health Canada issued three ...
...nter for Cell Phone Applications in Healthcare (C-... Members, BOSTON, Aug. 25 Medical Records Instit...lications in Healthcare (C-PAHC), a,membership-bas...0080825/NEM092LOGO ), C-PAHC envisions the devel...
Other Medicine News:Health News:Pioneering Neurosciences Institute Sets Date for Dedication of New Facility and First-Ever International Forum on Memory and Memory Disorders 2Health News:Pioneering Neurosciences Institute Sets Date for Dedication of New Facility and First-Ever International Forum on Memory and Memory Disorders 3Health News:Shaping Best Practices For Standardized Medical Imaging In Clinical Trials 2Health News:Shaping Best Practices For Standardized Medical Imaging In Clinical Trials 3Health News:QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc. 2Health News:QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc. 3Health News:Mindray Releases Historical Financial Results Converted into US Dollar Terms 2Health News:Antipsychotic Drug Use Up in Elderly Despite Warnings 2Health News:Medical Records Institute Unveils Platform for Studying Cell Phone Applications in Healthcare 2
(Date:11/25/2009)...FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicald...ydisruptivesurgicaltreatmentsforthespine,announced...r30,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecall...theCompany,sproductsandwillincludecommentsfrommana...dial-innumbersare1-877-407-4018fordomesticcallersa...
(Date:11/25/2009)...-Reportlinker.comannouncesthatanewmarketresearchre...ugDelivery-USMarketTrends&Analysis http://www...y---US-Market-Trends--Analysis.html ,, TheUSin...ftherapeuticapplicationsfromthedeliveryofconventio...rapeuticdrugs.Thefutureofthetechnologyhingesontoth...
(Date:11/25/2009)...PRNewswire/-- ChemoCentryx,Inc.,announcedtodaytha...theProspectiveRandomizedOralTherapyEvaluationinCro...entswithmoderate-to-severeCrohn,sdiseasedemonstrat...ityprofile.Thestudydemonstratedevidenceofclinicale...70-pointdecreaseintheCrohn,sDiseaseActivityIndex(C...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Embarrassing illnesses no bar to information sharing 52625 1Embarrassing illnesses no bar to information sharing 52625 2URI researcher sheds light on man eating squid 3B finds them timid non threatening 9340 1URI researcher sheds light on man eating squid 3B finds them timid non threatening 9340 2URI researcher sheds light on man eating squid 3B finds them timid non threatening 9340 3Caraco Pharmaceutical Laboratories Ltd Announces Filing of Purported Class Action Lawsuits 52622 1Caraco Pharmaceutical Laboratories Ltd Announces Filing of Purported Class Action Lawsuits 52622 2
...Biopure Corporation,(Nasdaq: BPUR ) announced tod...RC) has submitted a new protocol for review by the...clinical trial of Hemopure(R),[hemoglobin glutamer...f,operational casualties with severe traumatic hem...fusions. The proposed trial hypotheses is that,for...
...ts To Breathe Without Ventilator Clini...AND, June 18 Synapse Biomedical Inc., (http://www...ceived approval from,the U.S. Food and Drug Admini...r-dependent Spinal Cord Injury (SCI) patients who ...he FDA,s approval, SCI patients and,their caregive...
Other Medicine Technology:U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R) 2U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R) 3Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 2Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 3Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 4Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 5Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications 6
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: